GLYZORLLY-60M
Gliclazide (Modified Release) and Metformin Hydrochloride (Sustained Release) Tablets
Brand :- GLYZORLLY-60M
Pack Size : 10X10
Pack Type : B/P
Description :
GLYZORLLY-60M Tablets contain Gliclazide 60 mg (Modified Release) and Metformin Hydrochloride 500 mg (Sustained Release), a combination used for the management of type 2 diabetes mellitus. Gliclazide helps stimulate insulin secretion from the pancreas to reduce blood sugar levels, while Metformin decreases glucose production in the liver and improves insulin sensitivity. The modified and sustained release formulation provides gradual drug release for long-lasting glycemic control, helping maintain stable blood glucose levels and supporting overall metabolic health when used under medical supervision.
Products
ORLLYFORD